- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Events 232 results
Webinar
May 18, 2022
Trending Now: Privacy and Cybersecurity Regulations
Webinar
May 17, 2022
How PFAS Legal Issues Impact Companies in Real Life: Representative Case Studies
Webinar
April 20, 2022
Regulation of Cell and Gene Therapies: An Overview
Webinar
April 6, 2022
Data Governance in Healthcare
Webinar
March 30, 2022
Maximizing Contract and Treaty-Based Protections For Cross-Border Transactions in the Pharmaceutical Industry
Webinar
March 16, 2022
Impact of the Russia and Ukraine Conflict on the Financial Services Industry
Webinar
March 9, 2022
Russia and Ukraine: Strategies for Trade Compliance and Business Continuity
Webinar
March 8, 2022
Talk im Turm: Update MiFID II – News on Investment Advice/Brokerage and Inducements
Webinar
March 3, 2022
PFAS Regulatory and Litigation Impacts: What to Expect in 2022
Webinar
February 24, 2022
Navigating the Future: Considerations Related to “Femtech” and Other Digital Health Tools
Webinar
February 15, 2022
Environmental Justice in Regulatory Permitting, Transactions, and Litigation
Webinar
February 9, 2022
Does the Digital Markets Act Increase Legal Risks for Non-Gatekeeper Platforms?